Skip to main content

Research and statistics

Skip to results
412 results that are All research and statistics, sorted by Updated (newest)
From UK Health Security Agency (UKHSA)
  • Report on the uptake of influenza vaccine in GP patients during the 2023 to 2024 influenza vaccination programme in England.

  • Analysis of data on non-travel associated shigella infections in England.

  • Evaluation of the ninth year of the shingles vaccination programme in England: financial year 2022 to 2023.

  • This rapid mapping review identifies and categorises evidence on the health equity impacts of climate change in the UK.

  • This rapid review summarises available evidence on infectious disease transmission risk in communal accommodation settings.

  • Quarterly reports, with commentary, on cases confirmed by UK Health Security Agency's Virus Reference Department or local laboratory testing.

  • This report (XXVI) is a review of suspected overexposures investigated by chromosomal aberration analysis.

  • Report presenting data for sexually transmitted infections (STIs) in the East of England.

  • Cumulative data showing the number of GP-registered patients in England having the seasonal influenza vaccine.

  • Cumulative weekly data on invasive pneumococcal disease (IPD) infections due to serotypes not in Prevenar 13 vaccine.

  • Cumulative data on invasive pneumococcal disease (IPD) infections due to serotypes in Prevenar 13 in England.

  • Qualitative assessment of the risk that Crimean-Congo haemorrhagic fever presents to the UK population.

  • Data showing the number and proportion of frontline healthcare workers (HCWs) in England having seasonal influenza and COVID-19 vaccines.

  • These reports summarise the performance of different lateral flow devices (LFDs) used across various test settings and services within the National Testing Programme.

  • This report outlines the findings of 2 large-scale asymptomatic testing interventions in education settings.

  • This report presents the comparison of the sensitivity data provided by the manufacturer in the instructions for use with that observed in the laboratories at Porton Down.

  • This paper presents empirical estimates of the impact of the TTSP scheme on testing uptake amongst those who received the payments.

  • Published papers by Public Health and Clinical Oversight team including modelling papers that outline the key points of testing for SARS-CoV-2.

  • Two evaluations commissioned to determine LFD performance when Delta and Omicron variants of SARS-CoV-2 were declared variants of concern (VOC) in the UK.

  • Evaluation reports from a programme of pilot projects to support self-isolation during the COVID-19 pandemic.